Talking it out: psychotherapy shows promise for depressed breast cancer patients
NCT ID NCT06546787
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether interpersonal psychotherapy (a type of talk therapy) could help breast cancer patients who are at risk for depression. Forty-two patients with stage II or III breast cancer took part. The therapy aimed to lower depression scores and improve how patients manage emotions and feel supported by others. Results are expected to show whether this approach can be a helpful addition to cancer care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- interpersonal psychotherapy (talk therapy)
- What this could lead to
- If effective, this therapy could offer a non-drug way to ease depression and boost emotional well-being in breast cancer patients.
- What could go wrong
- This is a small, completed study with only 42 participants, so results may not apply to all patients. The therapy requires time and internet access, which may limit its use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
42 people
The number who actually took part.
- Started
-
Aug 2024
- Finished
-
Jul 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Includes Criteria * Ability to communicate in Turkish * Diagnosed with Stage-II and Stage-III breast cancer * Continuing outpatient treatment * Four points on the Primary Care Depression Screening Scale * Internet connection * Has a phone that can use the zoom app to continue conversations to be * To be able to use the Zoom app Exclusion Criteria * Being a pediatric oncology/hematology patient * Diagnosed with stage -IV breast cancer * Taking psychopharmacological medication * To have received KIPT within the last year
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer patients diagnosed are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Koc University
Istanbul, Nursing Department, 34020, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.